The “Psychiatric Treatment Adverse Reactions” (PsyTAR) dataset contains patients’ expression of effectiveness and adverse drug events associated with psychiatric medications. The PsyTAR was generated in four phases. In the first phase, a sample of 891 drugs reviews posted by patients on an online healthcare forum, “askapatient.com”, was collected for four psychiatric drugs: Zoloft, Lexapro, Cymbalta, and Effexor XR. For each drug review, patient demographic information, duration of treatment, and satisfaction with the drugs were reported. In the second phase, sentence classification, drug reviews were split to 6009 sentences, and each sentence was labeled for the presence of Adverse Drug Reaction (ADR), Withdrawal Symptoms (WDs), Sign/Sympt...
International audienceBackground: The Food and Drug Administration (FDA) in the United States and th...
Background: Hospital data based monitoring of ADRs can shed light on their extensiveness and pattern...
BACKGROUND: According to the World Health Organization (WHO) the cost of adverse drug reactions (ADR...
The “Psychiatric Treatment Adverse Reactions” (PsyTAR) dataset contains patients’ expression of effe...
Psychiatric Treatment Adverse Reactions (PsyTAR) corpus is an annotated corpus that has been develo...
Abstract Psychopharmacological drugs are used in the treatment of different types of psychotropic d...
ObjectiveMining the data contained within Electronic Health Records (EHRs) can potentially generate ...
Background: To analyse adverse drug reactions (ADRs) reported in patients prescribed psychiatric med...
UWM-Adverse Drug Events Corpus (UWM-ADEC) is an annotated corpus that has been developed from consum...
Electronic healthcare records (EHRs) are a rich source of information, with huge potential for secon...
Aims To develop a systematic generic method of enabling patients to report Symptoms which they belie...
The Author(s) 2014. This article is published with open access at Springerlink.com Background Data c...
Background: Adverse drug reactions (ADRs) are the prime determinants of non-adherence to drugs. In p...
Purpose: To develop a methodology for extracting psychotropic drug exposure data from computer-based...
Modern lifestyle and unfulfilled desires leads to very common diseases of today like anxiety, depres...
International audienceBackground: The Food and Drug Administration (FDA) in the United States and th...
Background: Hospital data based monitoring of ADRs can shed light on their extensiveness and pattern...
BACKGROUND: According to the World Health Organization (WHO) the cost of adverse drug reactions (ADR...
The “Psychiatric Treatment Adverse Reactions” (PsyTAR) dataset contains patients’ expression of effe...
Psychiatric Treatment Adverse Reactions (PsyTAR) corpus is an annotated corpus that has been develo...
Abstract Psychopharmacological drugs are used in the treatment of different types of psychotropic d...
ObjectiveMining the data contained within Electronic Health Records (EHRs) can potentially generate ...
Background: To analyse adverse drug reactions (ADRs) reported in patients prescribed psychiatric med...
UWM-Adverse Drug Events Corpus (UWM-ADEC) is an annotated corpus that has been developed from consum...
Electronic healthcare records (EHRs) are a rich source of information, with huge potential for secon...
Aims To develop a systematic generic method of enabling patients to report Symptoms which they belie...
The Author(s) 2014. This article is published with open access at Springerlink.com Background Data c...
Background: Adverse drug reactions (ADRs) are the prime determinants of non-adherence to drugs. In p...
Purpose: To develop a methodology for extracting psychotropic drug exposure data from computer-based...
Modern lifestyle and unfulfilled desires leads to very common diseases of today like anxiety, depres...
International audienceBackground: The Food and Drug Administration (FDA) in the United States and th...
Background: Hospital data based monitoring of ADRs can shed light on their extensiveness and pattern...
BACKGROUND: According to the World Health Organization (WHO) the cost of adverse drug reactions (ADR...